M
Michael L. Terrin
Researcher at University of Maryland, Baltimore
Publications - 139
Citations - 17598
Michael L. Terrin is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Randomized controlled trial & Myocardial infarction. The author has an hindex of 49, co-authored 132 publications receiving 16139 citations. Previous affiliations of Michael L. Terrin include Mount Sinai St. Luke's and Mount Sinai Roosevelt & University of Cincinnati.
Papers
More filters
Journal ArticleDOI
Aortic Calcification Is Associated with Decreased Abdominal Aortic Aneurysm Growth
Sydney L. Olson,Tanner I. Kim,Valentyna Kostiuk,John A. Curci,Jon S. Matsumura,B. Timothy Baxter,William C. Blackwelder,Michael L. Terrin,Raul J. Guzman +8 more
TL;DR: In this paper , the authors investigated the relationship between abdominal aortic calcification and AAA growth via post-hoc analysis of the Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial (N-TA3CT).
Journal ArticleDOI
Electrocardiographic enzymatic and scintigraphic criteria for diagnosis of acute myocardial infarction.
Journal ArticleDOI
Continuous intravenous epoprostenol improved survival, clinical status and hemodynamics in patients with severe primary pulmonary hypertension.
Azithromycin to Prevent Bronchopulmonary Dysplasia in Ureaplasma-infected Preterm
Rose M. Viscardi,Ahmed A. Othman,Hazem E. Hassan,Natalie D. Eddington,Elias Abebe,Michael L. Terrin,David A. Kaufman,Ken B. Waites,U. Virginia +8 more
TL;DR: In this article, the authors presented a study of the relationship between Pediatrics and Industrial Pharmacy at the University of Maryland School of Medicine and U.S. Department of Pediatrics and Epidemiology, University of Virginia, Charlottesville, VA.
Journal ArticleDOI
Design and rationale of the CHILL phase II trial of hypothermia and neuromuscular blockade for acute respiratory distress syndrome
Carl Shanholtz,Michael L. Terrin,Thelma Harrington,Whittney A. Warren,Robert Walter,Faith Armstrong,Rachel G. Scheraga,Perry Formanek,Michael Baram,Majid Afshar,Nathaniel Marchetti,Sunit Singla,J Reilly,Daniel B. Knox,Nitin Puri,Kevin K. Chung,Clayton H. Brown,Jeffrey D. Hasday +17 more
TL;DR: The Cooling to Help Injured Lungs (CHILL) trial as discussed by the authors is an open label, two group, parallel design multicenter, randomized phase IIB clinical trial assessing the efficacy and safety of targeted temperature management with combined external cooling and neuromuscular blockade to block shivering in patients with early moderate-severe acute respiratory distress syndrome (ARDS).